Palo Alto Investors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,010,833
| Closed | -$7.3M | – | 46 |
|
|
2024
Q3 | $7.3M | Hold |
1,010,833
| – | – | 0.95% | 21 |
|
|
2024
Q2 | $11M | Buy |
1,010,833
+5,057
| +0.5% | +$54.9K | 1.27% | 15 |
|
|
2024
Q1 | $18.8M | Buy |
1,005,776
+14,251
| +1% | +$267K | 2.13% | 13 |
|
|
2023
Q4 | $21.5M | Sell |
991,525
-14,251
| -1% | -$309K | 1.94% | 12 |
|
|
2023
Q3 | $20.7M | Buy |
1,005,776
+146,259
| +17% | +$3.01M | 1.96% | 10 |
|
|
2023
Q2 | $40.4M | Hold |
859,517
| – | – | 3.27% | 10 |
|
|
2023
Q1 | $36.1M | Buy |
859,517
+3,000
| +0.4% | +$126K | 2.99% | 10 |
|
|
2022
Q4 | $32.7M | Buy |
856,517
+5,108
| +0.6% | +$195K | 2.79% | 10 |
|
|
2022
Q3 | $33.3M | Hold |
851,409
| – | – | 2.64% | 10 |
|
|
2022
Q2 | $27.5M | Sell |
851,409
-310
| -0% | -$10K | 2.4% | 10 |
|
|
2022
Q1 | $28.2M | Buy |
851,719
+69,989
| +9% | +$2.32M | 2.18% | 12 |
|
|
2021
Q4 | $33.3M | Buy |
781,730
+163,800
| +27% | +$6.97M | 2.13% | 15 |
|
|
2021
Q3 | $27.4M | Buy |
617,930
+17,430
| +3% | +$772K | 1.65% | 16 |
|
|
2021
Q2 | $34.1M | Hold |
600,500
| – | – | 1.88% | 15 |
|
|
2021
Q1 | $44.9M | Buy |
600,500
+10,300
| +2% | +$771K | 2.56% | 14 |
|
|
2020
Q4 | $51.1M | Hold |
590,200
| – | – | 2.68% | 14 |
|
|
2020
Q3 | $36.1M | Buy |
590,200
+15,000
| +3% | +$917K | 1.98% | 14 |
|
|
2020
Q2 | $23.9M | Sell |
575,200
-11,474
| -2% | -$477K | 1.44% | 17 |
|
|
2020
Q1 | $16.8M | Sell |
586,674
-66,920
| -10% | -$1.92M | 1.41% | 17 |
|
|
2019
Q4 | $47.2M | Sell |
653,594
-27,300
| -4% | -$1.97M | 2.6% | 16 |
|
|
2019
Q3 | $95.5M | Sell |
680,894
-114,137
| -14% | -$16M | 6.36% | 6 |
|
|
2019
Q2 | $146M | Sell |
795,031
-62,650
| -7% | -$11.5M | 7.08% | 4 |
|
|
2019
Q1 | $136M | Buy |
857,681
+6,704
| +0.8% | +$1.07M | 5.69% | 7 |
|
|
2018
Q4 | $81.5M | Buy |
850,977
+10,605
| +1% | +$1.02M | 4.34% | 9 |
|
|
2018
Q3 | $119M | Buy |
840,372
+7,836
| +0.9% | +$1.11M | 4.8% | 8 |
|
|
2018
Q2 | $130M | Buy |
832,536
+14,205
| +2% | +$2.22M | 5.21% | 7 |
|
|
2018
Q1 | $132M | Buy |
818,331
+7,525
| +0.9% | +$1.21M | 5.64% | 6 |
|
|
2017
Q4 | $134M | Buy |
810,806
+23,555
| +3% | +$3.88M | 5.75% | 7 |
|
|
2017
Q3 | $49M | Sell |
787,251
-245,774
| -24% | -$15.3M | 2.07% | 14 |
|
|
2017
Q2 | $82.3M | Sell |
1,033,025
-68,926
| -6% | -$5.49M | 3.84% | 8 |
|
|
2017
Q1 | $78.3M | Buy |
1,101,951
+92,021
| +9% | +$6.54M | 3.7% | 10 |
|
|
2016
Q4 | $51.6M | Buy |
1,009,930
+107,879
| +12% | +$5.51M | 2.94% | 11 |
|
|
2016
Q3 | $41.5M | Buy |
902,051
+484,173
| +116% | +$22.3M | 2.41% | 15 |
|
|
2016
Q2 | $12.6M | Buy |
+417,878
| New | +$12.6M | 0.95% | 26 |
|